epigallocatechin gallate has been researched along with hydroxychloroquine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J; Chen, W; Choudhry, N; Xu, D; Yang, Z; Zanin, M; Zhao, X | 1 |
| Banerjee, A; Maiti, S | 1 |
1 review(s) available for epigallocatechin gallate and hydroxychloroquine
| Article | Year |
|---|---|
Chinese Therapeutic Strategy for Fighting COVID-19 and Potential Small-Molecule Inhibitors against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
Topics: Antiviral Agents; China; Coronavirus Protease Inhibitors; COVID-19; COVID-19 Drug Treatment; Drugs, Chinese Herbal; Humans; Medicine, Chinese Traditional; SARS-CoV-2; Small Molecule Libraries | 2020 |
1 other study(ies) available for epigallocatechin gallate and hydroxychloroquine
| Article | Year |
|---|---|
Epigallocatechin gallate and theaflavin gallate interaction in SARS-CoV-2 spike-protein central channel with reference to the hydroxychloroquine interaction: Bioinformatics and molecular docking study.
Topics: Angiotensin-Converting Enzyme 2; Biflavonoids; Binding Sites; Catechin; Computational Biology; COVID-19; Gallic Acid; Humans; Hydroxychloroquine; Molecular Docking Simulation; Protein Structure, Secondary; Protein Structure, Tertiary; Spike Glycoprotein, Coronavirus; X-Ray Diffraction | 2021 |